saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet

RxCUI: 858036
RxNorm name: saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet
Display name: saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet
Full name: saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SAXAGLIPTIN	SAXAGLIPTIN	Glenmark Pharmaceuticals Inc., USA	e286ffd4-c598-47fb-af06-2e15f7e6f99f	2026-01-27	Warnings, Adverse reactions	Exact identifier rxcui: 858036
Saxagliptin	SAXAGLIPTIN	Mylan Pharmaceuticals Inc.	6e8d8c4f-96eb-4b64-9c8c-4a5448a23a78	2025-02-28	Warnings, Adverse reactions	Exact identifier rxcui: 858036
Saxagliptin	SAXAGLIPTIN	Aurobindo Pharma Limited	f3ea58bb-0002-4a5d-9213-7e9066e3dc9c	2024-12-04	Warnings, Adverse reactions	Exact identifier rxcui: 858036

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
6e8d8c4f-96eb-4b64-9c8c-4a5448a23a78	saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet	SY	4	These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS . SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 2009	20250228
6e8d8c4f-96eb-4b64-9c8c-4a5448a23a78	sAXagliptin 5 MG Oral Tablet	PSN	4	These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS . SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 2009	20250228
6e8d8c4f-96eb-4b64-9c8c-4a5448a23a78	saxagliptin 5 MG Oral Tablet	SCD	4	These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS . SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 2009	20250228
f3ea58bb-0002-4a5d-9213-7e9066e3dc9c	saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet	SY	3	These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS. SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 2009	20241204
f3ea58bb-0002-4a5d-9213-7e9066e3dc9c	saxagliptin 5 MG Oral Tablet	SCD	3	These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS. SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 2009	20241204
f3ea58bb-0002-4a5d-9213-7e9066e3dc9c	sAXagliptin 5 MG Oral Tablet	PSN	3	These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS. SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 2009	20241204
d45fc842-2563-4421-86af-a55b3191e19b	saxagliptin 5 MG Oral Tablet	SCD	3	These highlights do not include all the information needed to use ONGLYZA safely and effectively. See full prescribing information for ONGLYZA. ONGLYZA (saxagliptin) tablets Initial U.S. Approval: 2009	20120109
d45fc842-2563-4421-86af-a55b3191e19b	sAXagliptin 5 MG Oral Tablet	PSN	3	These highlights do not include all the information needed to use ONGLYZA safely and effectively. See full prescribing information for ONGLYZA. ONGLYZA (saxagliptin) tablets Initial U.S. Approval: 2009	20120109
d45fc842-2563-4421-86af-a55b3191e19b	saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet	SY	3	These highlights do not include all the information needed to use ONGLYZA safely and effectively. See full prescribing information for ONGLYZA. ONGLYZA (saxagliptin) tablets Initial U.S. Approval: 2009	20120109
e286ffd4-c598-47fb-af06-2e15f7e6f99f	saxagliptin 5 MG Oral Tablet	SCD	2	These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS. SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 2009	20260127
e286ffd4-c598-47fb-af06-2e15f7e6f99f	saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet	SY	2	These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS. SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 2009	20260127
e286ffd4-c598-47fb-af06-2e15f7e6f99f	sAXagliptin 5 MG Oral Tablet	PSN	2	These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS. SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 2009	20260127